Why a Buyout Deal May Not Be in the Cards for Acadia Post author:Sam Post published:November 27, 2017 Post category:BioPharma A look at why a potential buyout of Acadia might not be as likely as some have suggested. Source: BioSpace You Might Also Like <b>Gottlieb</b> Lays Out Plans to Attract and Preserve Top Talent at the FDA July 17, 2017 SoCal's USGI Medical Names Former ConMed Exec as CEO April 18, 2017 Life Science Companies are Litigation Targets for Unhappy Investors February 22, 2018